Cargando…
Peroxiredoxins - Urinary Surveillance Biomarkers in Urothelial Cancer
Introduction: Urinary bladder cancer ranks the fourth most common cancer in men worldwide. Peroxiredoxins (PRDXs) are antioxidant enzymes that play an important role in cell proliferation and apoptosis. In the present study, we investigated whether PRDX 1 and 2 can be used as a urinary biomarker for...
Autores principales: | Kumari, Nitu, Vasudeva, Pawan, Tanwar, Pranay, Hussain, Showket, Kumar, Anup, Agrawal, Usha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254872/ https://www.ncbi.nlm.nih.gov/pubmed/35812179 http://dx.doi.org/10.7150/jca.69811 |
Ejemplares similares
-
High-Grade Urothelial Carcinoma of Bladder Transforming to Micropapillary Variant on Follow-Up
por: Kumari, Nitu, et al.
Publicado: (2017) -
Structural and conformational changes induced by missense variants in the zinc finger domains of GATA3 involved in breast cancer
por: Kumar, Rakesh, et al.
Publicado: (2020) -
Impact of family medicine practice in combating Violence against Doctors
por: Tanwar, Pranay, et al.
Publicado: (2019) -
Molecular basis of epigenetic regulation in cancer diagnosis and treatment
por: Tulsyan, Sonam, et al.
Publicado: (2022) -
Urothelial Bladder Cancer Urinary Biomarkers
por: Noon, Aidan P, et al.
Publicado: (2014)